Apart from the MOBP rs616147—ALS direct association, a dose-dependent pharmacogenetic interaction has been recently revealed between the A allele of rs616147 and creatine administration to patients with ALS [33]. Here, MOBP is linked to amyotrophic lateral sclerosis.